Suzuka Chiba, Wakana Kusuhara, Eri Ishikawa, Makoto Yoritate, Taishi Miura, Kazushi Maeda, Haruto Takamura, Hiroaki Matoba, Sho Yamasaki, Go Hirai
Despite recent advances, highly stereoselective C -glucosylation for the synthesis of glycan analogs with diverse C -glycoside linkages (linkage-edited pseudoglycans) remains a considerable challenge. Here, we present a β-selective C -glucosylation method using a 2,4-bis(triisopropylsilyl)-protected glucosyl bromide donor. Direct coupling with ceramide and cholesterol-derived bromofluoroolefins provides access to analogs of β-glucosylceramide (pseudo-β-GlcCer) and β-glucosylcholesterol (pseudo-β-GlcChol) containing CH 2 -, ( R )–CHF-, and ( S )–CHF-linkages. Pseudo-β-GlcCers activated immune responses in mouse bone marrow-derived macrophages and dendritic cells more potently than native β-GlcCer, with distinct immune activity patterns, depending on the linkage type.